• No notifications yet.
  • Edit Profile
  • Settings
  • Invite Friends
  • Sign Out
logo image
  • logo image
Registered User? Login

Access to our event community is available to Professional, Speaker, Sponsor and VIP ticket holders only.  If you have not received the access code or would like to upgrade your ticket please get in touch with a member of the team at  ftlive@ft.com

Forgot Password?
Sign Up
loader image
New User? Sign Up

Access to our event community is available to Professional, Speaker, Sponsor and VIP ticket holders only.  If you have not received the access code or would like to upgrade your ticket please get in touch with a member of the team at  ftlive@ft.com

Forgot Password?
Login
loader image

    US Pharma and Biotech Summit

    May 5 - 6, 2021
    #FTUSPharma

    Global sponsors

    Global Clinical Research Partner
    Partner logo

    Sponsors

    Lead Sponsor
    Partner logo
    Associate Sponsor
    Partner logo

    It’s been a year of urgency, innovation and collaboration in healthcare and life sciences. The US Pharma and Biotech Summit is the essential virtual event for business leaders, innovators and policymakers to explore how the sector can adapt to meet a new set of challenges and opportunities for the post-pandemic era.

    Central Themes

    Leading and learning
    The legacy of collaboration during the pandemic, matters of trust in the industry, strategies for workforce development and perspectives on the investment landscape
    Innovating and enabling
    The potential of advanced therapies, the rise of artificial intelligence, new frontiers for diagnostics and the future of clinical trials
    Scaling up and ensuring access
    The evolution of manufacturing and supply chains, prospects for US healthcare reform, market access strategies and ways to become more patient-centric

    2020 world-class business leaders and speakers included

    image placeholder
    SM
    Stephen M. Hahn
    Commissioner
    U.S. Food & Drug Administration (FDA)
    image placeholder
    JM
    Jessica Mega
    Chief Medical & Scientific Officer
    Verily
    image placeholder
    SB
    Stéphane Bancel
    Chief Executive Officer
    Moderna Therapeutics
    image placeholder
    SS
    Susan Shiff
    SVP, Centre for Observational and Real World Evidence
    MSD
    image placeholder
    RB
    Robert Bradway
    Chairman and CEO
    Amgen
    image placeholder
    TW
    Terry Wilcox
    Executive Director
    Patients Rising

    Moderator

    image placeholder
    HK
    Hannah Kuchler
    US Pharma and Biotech Correspondent
    Financial Times

    "A great way to gather insights and learn from the leaders in our field."

    Why attend?


    Discuss
    the pharma industry's response to COVID-19 and whether the legacy of collaboration can continue

    Examine
    new proposals for healthcare reform and query their potential to reshape the market

    Explore
    applications for AI in R&D and debate the impact on company culture

    Learn
    what it really means to be “patient-centric” and how it can support strategic goals

    Assess
    the potential of advanced therapies and consider challenges around market access